Project Grant R03AR085215
- The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $644,152 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant, with a period of performance from January 20, 2025 to December 31, 2029, will support research to identify the underlying mechanistic pathway linking aberrant limb-level loading during walking to the development of knee...
- This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $564,442 to North Carolina State University to better understand outcomes after complete and partial ACL (anterior cruciate ligament) reconstruction in growing knee joints. The research aims to leverage the porcine model to evaluate surgical techniques for restoring joint stability and...
- The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $500,000.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420), administered by the Defense Health Agency. The funding supports a research project titled "A NOVEL DRUG DISCOVERY APPROACH FOR PREVENTING POSTTRAUMATIC OSTEOARTHRITIS" with a performance period from July 1, 2025 to June 30, 2027. The research aims to develop innovative medical solutions for addressing critical health...
- The University of Pittsburgh was awarded a $147,236 Project Grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846). The project aims to quantify the mechanical effects of knee bracing and predict its ability to prevent ligamentous injuries, such as injuries to the medial collateral ligament (MCL) and anterior cruciate ligament (ACL). The researchers will use a...
- This $361,300 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846) will support research to identify new cell signaling pathways and therapeutic targets for disease modification in osteoarthritis (OA). The University of North Carolina at Chapel Hill will conduct high-throughput screening of small molecules to discover signaling pathways...
- This $556,160 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (CFDA 93.846) aims to examine the efficacy of a rehabilitation approach called Rehabilitation with Exercise and Psychological Support (REPS) for patients who have undergone ACL reconstruction surgery. The REPS intervention integrates standard exercise rehabilitation with psychological support, including clinician training, patient education videos, and techniques like...
- This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), is intended to elucidate the effects of blood and blood-derived components on meniscus tissue homeostasis, repair, and post-traumatic osteoarthritis development. The $487,652 award to Duke University will fund research to investigate the mechanisms by which blood-derived immune...
- The University of Southern California (USC) received a $628,174 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846). The purpose of this multi-year grant, with an ultimate completion date of March 31, 2030, is to support research into the cellular origins and molecular mechanisms underlying the development of arthrofibrosis, a debilitating...
- This Project Grant award, valued at $196,460.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The purpose of the award is to test a miniature knee joint system as a new tool to study the role of neuro-immune interactions in osteoarthritis pain. The University of Pittsburgh, the awardee, will use this novel microphysiological system with cartilage,...
- The University of North Carolina at Chapel Hill received a $310,295 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program. The grant, awarded on September 11, 2025, with a completion date of September 10, 2027, supports research to identify subgroups of adolescents with chronic temporomandibular disorder (TMD) pain in order to guide personalized treatment approaches. The project aims to...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $165,527 Project Grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846). The grant is for a longitudinal study to characterize injury-related fear in patients after anterior cruciate ligament (ACL) reconstruction. The research aims to identify trajectories of injury-related fear throughout rehabilitation and how patients perceive these fears to impact their recovery. This work seeks to enhance the effectiveness of future psychological interventions to mitigate secondary ACL injury risk and improve long-term knee joint health. The project period is from Sep 1, 2025 to Aug 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $165.5k | 8/28/25 |